MAIA Biotechnology, Inc. (MAIA)

MAIA Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9.6	7.15	10.95	10.57	0.66
Cash & Short-Term Investments	9.6	7.15	10.95	10.57	0.66
Cash Growth	34.27%	-34.70%	3.56%	1493.82%	-61.19%
Other Receivables	0.08	0.14	0.3	0.04	-
Receivables	0.08	0.14	0.3	0.04	-
Prepaid Expenses	0.47	0.27	0.55	0.05	0.08
Total Current Assets	10.15	7.56	11.81	10.67	0.75
Long-Term Deferred Charges	-	-	0.21	0.65	-
Other Long-Term Assets	0	0	0	0	-
Total Assets	10.16	7.57	12.02	11.33	0.75
Accounts Payable	1.51	1.64	1.17	0.96	0.15
Accrued Expenses	2.32	3.3	2.1	1.19	1.51
Short-Term Debt	-	-	-	-	0.02
Current Portion of Long-Term Debt	-	-	-	-	0.01
Total Current Liabilities	3.83	4.94	3.27	2.15	1.69
Long-Term Debt	-	-	-	-	0.43
Other Long-Term Liabilities	2.69	2.15	0.25	-	0.24
Total Liabilities	6.52	7.09	3.51	2.15	2.36
Common Stock	0	0	0	0	0
Additional Paid-In Capital	90.9	64.47	52.73	37.62	12.6
Retained Earnings	-87.23	-63.98	-44.21	-28.44	-15.93
Comprehensive Income & Other	-0.03	-0.02	-0.02	-	-0
Total Common Equity	3.63	0.48	8.51	9.18	-3.34
Minority Interest	-	-	-	-	1.72
Shareholders' Equity	3.63	0.48	8.51	9.18	-1.62
Total Liabilities & Equity	10.16	7.57	12.02	11.33	0.75
Total Debt	-	-	-	-	0.46
Net Cash (Debt)	9.6	7.15	10.95	10.57	0.2
Net Cash Growth	34.27%	-34.70%	3.56%	5195.01%	-88.08%
Net Cash Per Share	0.43	0.54	1.18	2.00	0.05
Filing Date Shares Outstanding	29.59	20	11	7.94	4.43
Total Common Shares Outstanding	26.16	16.99	10.96	7.58	4.43
Working Capital	6.32	2.63	8.54	8.53	-0.95
Book Value Per Share	0.14	0.03	0.78	1.21	-0.75
Tangible Book Value	3.63	0.48	8.51	9.18	-3.34
Tangible Book Value Per Share	0.14	0.03	0.78	1.21	-0.75

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q